📰 Cortex Pharmaceuticals News
Cortex Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cortex Pharmaceuticals. Real-time updates on events, politics, business and more.
August 2, 2023
RespireRx Pharmaceuticals (OTCMKTS:RSPI – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare RespireRx Pharmaceuticals to similar companies based on the strength of its profitability, dividends, risk, institutional ownership, earnings, valuation and analyst recommendations. Analyst Recommendations This […]
August 2, 2023
RespireRx Pharmaceuticals (OTCMKTS:RSPI – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare RespireRx Pharmaceuticals to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Volatility and Risk […]
June 13, 2023
Cortex Pharmaceuticals, Inc. 2014 Equity, Equity-Linked and Equity Derivative Plan PHANTOM STOCK AWARD AGREEMENT This Phantom Stock Award... | June 13, 2023
March 24, 2023
Dr Hank Mansbach, Chief Medical Officer of 89bio discusses clinical development of FGF21 therapy to treat fatty liver disease.
April 11, 2022
Technological advancements and multiple vendors with small and big sales that are heavily investing in pharmaceutical industry will drive huntington’s...
January 20, 2022
RespireRx Pharmaceuticals (OTCQB:RSPI) Inc is a tiny company with huge ambitions as it advances a portfolio of innovative drugs to combat neurological and...